Joerg Herrmann
Mayo Clinic in Rochester · Mayo Clinic
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Joerg Herrmann as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:10 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT07456852 · Vasodilator Therapy With Isosorbide Mononitrate or Diltiazem to Reduce Vasotoxicity in Patients With Gastrointestinal Cancer Receiving Fluoropyrimidine TherapyMayo Clinic · recruiting · Malignant Digestive System Neoplasm · principal investigator
- N/ANCT07058064 · WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)Mayo Clinic · recruiting · Lymphoma, Sarcoma · principal investigator
- N/ANCT06151730 · Evaluation of Hypertension Management and Cardiovascular Adverse Event Prevention in Patients With B-cell Malignancies Undergoing Treatment With Bruton Tyrosine Kinase Inhibitors, the HALT StudyMayo Clinic · recruiting · Chronic Lymphocytic Leukemia, Hematopoietic and Lymphoid System Neoplasm, Mantle Cell Lymphoma · principal investigator
- N/ANCT05201014 · Cancer Survivor Cardiomyopathy DetectionMayo Clinic · terminated · Cardiovascular Diseases, Cancer · principal investigator
- N/ANCT04664881 · Home Telemonitoring In Patients After Myocardial InfarctionMayo Clinic · completed · Myocardial Infarction, Heart Attack · principal investigator
- Ph2NCT04190433 · Autophagy Activation for the Alleviation of Cardiomyopathy Symptoms After Anthracycline Treatment, ATACAR TrialMayo Clinic · withdrawn · Breast Carcinoma, Hematopoietic and Lymphoid Cell Neoplasm, Lymphoma · principal investigator
- Ph2NCT03879629 · Treating Breast Cancer Patients Undergoing Trastuzumab Treatment With Carvedilol to Reduce Incidence of Heart FailureMayo Clinic · terminated · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:10 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- TrAstuzumab Cardiomyopathy Therapeutic Intervention with Carvedilol (TACTIC) TrialR01CA233610 · NCI · MAYO CLINIC ROCHESTER · fiscal years 2019 to 2024 · $773,975 awarded in 2024Grant number is on one of their registry trials
- The pathophysiological role of the immunoproteasome in atherosclerosisK08HL116952 · NHLBI · MAYO CLINIC ROCHESTER · fiscal years 2014 to 2018 · $165,456 awarded in 2018Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.